September 17, 2018
A New Jersey federal judge has refused to toss claims in a hedge fund group's lawsuit accusing Valeant Pharmaceuticals International Inc. of duping investors about the sustainability of its business model, ruling on Friday that the claim wasn't filed too late under federal securities law.
September 28, 2017
Valeant Pharmaceuticals International Inc. misrepresented to investors that its growth was driven by acquisitions rather than by deceptive sales practices, ultimately causing shares to plunge more than 90 percent, shareholders claimed Wednesday in New Jersey federal court.